This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

PyroGenesis Inc.
11/10/2023
Good day, and thank you for standing by. Welcome to the PyroGenesis 3rd Quarter 2023 Business Update Conference Call. At this time, all participants are in listen-only mode. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Rodina Cofell, Vice President, Investor Relations. Please go ahead.
Good morning, everyone, and thank you for joining PyroGenesis 2023 3rd Quarter Financial Results and Business Update Conference Call. On the call with us today are Phi Peter Pascali, CEO and President, Steve McCormick, Vice President of Corporate Affairs, and Andrew Manala, Chief Financial Officer. The company issued a press release on Thursday, November 9, 2023, containing a business update and financial results for the third quarter ending September 30, 2023, which can be viewed on the company's website. If you have any questions after the call, or would like any additional information about the company, please contact us. We've collected a number of questions in advance of the call. Many of these will be discussed during today's call. The company's management will now provide prepared remarks reviewing the operational and financial results for the third quarter ended September 30, 2023. I would like to remind everyone that this discussion will include forward-looking information that is based on certain assumptions and is subject to risks and uncertainties that could cause actual results to differ materially from historical results or results anticipated by the forward-looking information. Forward-looking information provided in this call speaks only as of the date of this call and is based on the plans, beliefs, estimates, projections, expectations, opinions, and assumptions of management as of today's date. There can be no assurance that forward-looking information will prove to be accurate, and you should not place reliance on forward-looking information. Pyrogenesis disclaims any obligation to update any forward-looking information or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. In addition, during the course of this call, There may also be reference to certain non-IFRS financial measures, including references to adjusted net loss and adjusted EBITDA, which do not have any standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other companies. For more information about both forward-looking information and non-IFRS financial measures, including a reconciliation of each of adjusted net loss and adjusted EBITDA, to net loss, please refer to the company's management discussion analysis, which along with the financial statement are available on the company's website at www.paragenesis.com and the company's corporate filings on Cedar Plus at cedarplus.ca. With that, I will now turn the call over to Steve McCormick, Vice President of Corporate Affairs. Please go ahead, Steve.
Thanks, Virginia, and thanks to everyone for joining us today on our call. I'm going to start off with a quick review of some of the company's top-line financials, followed by a summary of key business activities that occurred during the quarter, before turning the call over to the company's Chief Financial Officer, Andre Minella. I'd like to first start off with an update on the company's status as a dual-listed public company. Post-quarter end on October 27, 2023, after careful consideration, the Board of Directors decided and the company announced that it would be ending its dual listing status by voluntarily delisting from the NASDAQ exchange. The decision would not affect its listing on the Toronto Stock Exchange, and the company remains public and will so continue to trade on the TSX. As background, for some time the company had been evaluating the costs and benefits of maintaining a dual listing on both NASDAQ and the TSX. That ongoing evaluation entailed an analysis of several key factors, including the historical advantages of dual listed companies, the financial costs associated with being on the NASDAQ, such as insurance, regulatory compliance, legal fees and accounting, the low volume of trading on the NASDAQ, and the regulatory and compliance requirements that mandated significant professional hours and duplication of effort, an additional obligation for a Quebec-based company that already has to meet compliance and filing requirements in two languages. Cost of pyrogenesis associated to its dual listing in the U.S. were considerable, with incremental U.S.-specific fees related to directors and officer insurance, legal, listing and filings, and accounting of more than $2.2 million, which would require approximately $6 to $8 million in gross revenue. Ultimately, the board of directors decided that, after weighing all of the above, a dual listing was not providing significant benefit, and the company would voluntarily delist from the NASDAQ exchange. Again, this decision does not affect its listing on the Toronto Stock Exchange. The company has taken steps to have its shares quoted over the counter on the US-based OTCQX Best Market. The company has initiated the NASDAQ delisting process and has filed the required Form 25 with the SEC for the removal of its shares from NASDAQ. This form is anticipated to become effective 10 days following, resulting in a delisting of the company shares from NASDAQ on or about November 16th of 2023. Now back to the financial summary. First, a reminder that pyrogenesis follows Canadian generally accepted accounting principles or GAAP, where revenue is accrued not on sales, but on a model that reflects a percentage of the work completed for long-term contracts during the period, which can vary. based on both the nature of the projects in-house and on a client's own scheduling and logistical decisions, both of which can impact production milestones and the company's ability to book revenue. During these recent years of supply chain, logistical, and inflationary uncertainties, those issues have been more frequent and exacerbating. And as stated in previous reports, the company's revenues are likely to be irregular and unpredictable quarter to quarter as contract-related revenue fluctuates based on various reasons, including those just explained. For the third quarter of 2023, the company exited the quarter with revenues of $3.7 million, which, while still low compared to the past two years, is the second consecutive quarter of growth from the revenue low point of two quarters ago in Q1 of 2023. As stated in yesterday's news release, we are seeing improvements across industrial supply chains and customer bottlenecks, and along with better-than-expected customer demand for new project starts, we anticipate the revenue momentum to continue and for Q4 to maintain the upward trend of Q2 and Q3. Gross margin was 30%. This is comparable to industries the company serves and consistent with margin pressures being seen across those industries who continue to have difficulty maintaining 2022 level margins due to persistent inflationary environment for heavy industry and their customers. For comparison, the aluminum industry returned margins of 5.1%, aerospace and defense at 18.5%, iron and steel at 24.7%, and metal mining at 29%, all for Q3 results reported to date. One aspect pertaining to margin that is often overlooked is that because some of the company's projects are conducted in partnership, such as with clients like HQQ Silicon, where pyrogenesis has back-end royalty revenue potential on the client's end product or has sold intellectual property to the client, the engineering and production aspects are likely to be conducted with intentionally lower profit margins. Additionally, projects developed using government grant funding often have lower margin mandates. Both instances can affect the company's margin results based on the mix of work currently underway. As mentioned in the past, given that several of the company's technology solutions are either only recently commercialized or can have long time spans between orders of a similar type system, we regard any high or even medium-sized margins at such an early stage as both positive and a strong sign for the future. And finally, to backlog. Corresponding to increasing customer demand, the backlog continues to rise, up more than $1 million to $35 million. This represents the 13th out of the last 16 quarters above $30 million in backlog since the company first reached that mark in 2019. Overall, the financials for the third quarter were an improvement on Q2 by 21% and on Q1 by 42%, and while not yet back to the levels produced by 2021, 2021 and 2022 represents continued momentum in the right direction both for the company and its customers to continue to press forward on slower moving projects while resolving their own bottlenecks.
You're reading a preview of the PYR Q3 2023 earnings call.
Free account.